rs150797476
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014391.3(ANKRD1):c.197G>A(p.Arg66Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000674 in 1,613,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R66G) has been classified as Benign.
Frequency
Consequence
NM_014391.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD1 | NM_014391.3 | c.197G>A | p.Arg66Gln | missense_variant | 2/9 | ENST00000371697.4 | NP_055206.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD1 | ENST00000371697.4 | c.197G>A | p.Arg66Gln | missense_variant | 2/9 | 1 | NM_014391.3 | ENSP00000360762 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000874 AC: 133AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000935 AC: 235AN: 251288Hom.: 0 AF XY: 0.000825 AC XY: 112AN XY: 135830
GnomAD4 exome AF: 0.000653 AC: 955AN: 1461504Hom.: 0 Cov.: 32 AF XY: 0.000686 AC XY: 499AN XY: 727062
GnomAD4 genome AF: 0.000873 AC: 133AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.000766 AC XY: 57AN XY: 74460
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:5Other:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | ANKRD1: BP4, BS1 - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 31, 2017 | Variant summary: The ANKRD1 c.197G>A (p.Arg66Gln) variant involves the alteration of a non-conserved nucleotide, resulting in a missense change in the ankyrin repeat-containing domain (InterPro). 4/5 in silico tools predict benign outcome for this variant. This variant was found in 116/122204 control chromosomes (ExAC) at a frequency of 0.0009492, which is approximately 28 times the estimated maximal expected allele frequency of a pathogenic ANKRD1 variant (0.0000344), suggesting this variant is likely a benign polymorphism. In gnomAD, the variants allele frequency is 0.001079 (299/ 277022 chromosomes). This variant has been reported in one case who had family history of premature sudden deaths in first-degree relatives (Duboscq-Bidot_EJH_2009). Functional analysis in the same study showed a non-significant, mild effect on transcriptional repression was observed as well as a non-significant increase in cell area in cardiomyocytes, suggesting protein function is not significantly impacted by the variant. In ClinVar, while four clinical labs have classified it as uncertain significance, three have classified it as likely benign. Taken together, based on its allele frequency in general population and the possibility that it is likely to be a functional polymorphism rather than causal variant, this variant is classified as likely benign. - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 14, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 25, 2021 | This variant is associated with the following publications: (PMID: 22337857, 19525294, 23861362, 24503780, 23299917) - |
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | Variant interpretted as Uncertain significance and reported on 01-06-2017 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. - |
not specified Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 19, 2015 | proposed classification - variant undergoing re-assessment, contact laboratory - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Primary dilated cardiomyopathy Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Likely benign, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Jun 24, 2013 | - - |
Cardiomyopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Apr 25, 2018 | - - |
ANKRD1-related dilated cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at